US 12,214,004 B2
Strains having effects of preventing or treating cancers
Hansoo Park, Seoul (KR); Shinyoung Park, Gyeonggi-do (KR); Eun Ju Lee, Gyeonggi-do (KR); Jae-Sung Yeon, Gyeonggi-do (KR); Hye Hee Jeon, Gyeonggi-do (KR); Wonduck Kim, Gyeonggi-do (KR); Joo-Yeon Chung, Gyeonggi-do (KR); Areum Jeong, Gyeonggi-do (KR); Youn Kyung Houh, Gyeonggi-do (KR); Jinyoung Sohn, Gyeonggi-do (KR); Yun Yeon Kim, Gyeonggi-do (KR); Sang Gyun Kim, Gyeonggi-do (KR); and Suro Lee, Gyeonggi-do (KR)
Assigned to Genome And Company, Seongnam-Si (KR)
Filed by Genome And Company, Gyeonggi-do (KR)
Filed on Nov. 12, 2020, as Appl. No. 17/096,031.
Application 17/096,031 is a division of application No. 17/054,433, previously published as PCT/KR2019/005518, filed on May 8, 2019.
Claims priority of application No. 10-2018-0054195 (KR), filed on May 11, 2018; and application No. 10-2018-0133030 (KR), filed on Nov. 1, 2018.
Prior Publication US 2021/0138003 A1, May 13, 2021
Int. Cl. A61K 35/745 (2015.01); A61K 31/282 (2006.01); A61K 31/337 (2006.01); A61K 31/475 (2006.01); A61K 31/513 (2006.01); A61K 31/519 (2006.01); A61K 31/675 (2006.01); A61K 31/704 (2006.01); A61K 31/7048 (2006.01); A61K 31/7068 (2006.01); A61K 33/243 (2019.01); A61K 35/744 (2015.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01); A61P 35/00 (2006.01); C07K 16/28 (2006.01); C12N 1/20 (2006.01); A61K 39/00 (2006.01)
CPC A61K 35/745 (2013.01) [A61K 31/282 (2013.01); A61K 31/337 (2013.01); A61K 31/475 (2013.01); A61K 31/513 (2013.01); A61K 31/519 (2013.01); A61K 31/675 (2013.01); A61K 31/704 (2013.01); A61K 31/7048 (2013.01); A61K 31/7068 (2013.01); A61K 33/243 (2019.01); A61K 35/744 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01); C07K 16/2818 (2013.01); C07K 16/2827 (2013.01); C12N 1/205 (2021.05); A61K 2039/505 (2013.01); A61K 2039/545 (2013.01)] 17 Claims
 
1. A pharmaceutical composition comprising a Bifidobacterium bifidum MG731 strain KCTC13452BP and a pharmaceutically acceptable excipient, and further comprising an anticancer chemotherapeutic agent or an anticancer immunotherapeutic agent.